Anixa BiosciencesANIX 
$3.403.03%24h
3.03%24h
Global rank20947
Market cap$105.64M
Change 7d-
YTD Performance-12.82%
SP500 benchmarkUnderperform
P/E0
P/S503.04
Revenue$210.00K
Earnings-$9.93M
Dividend yield-
Anixa Biosciences (ANIX) Stock Price History
As for today ANIX price is $3.40, a increase of 3.03% from yesterday.
The highest price of Anixa Biosciences is $259.38 on 1993-07-01. It's also known as the all time high (ATH) which refers to the highest price ever reached by a stock in its trading history.
The lowest price of Anixa Biosciences is $0.60 on 2017-08-01. It's also known as the all time low (ATL) which refers to the lowest price ever reached by a stock in its trading history.
Stock Price History of Anixa Biosciences from to 2024.
-
Value:-
Stock price history for Anixa Biosciences by end of year
| Year | Price | Change |
|---|---|---|
| 2024 | $4.05 | 4.38% |
| 2023 | $3.88 | -8.71% |
| 2022 | $4.25 | 43.10% |
| 2021 | $2.97 | -3.26% |
| 2020 | $3.07 | -6.40% |
| 2019 | $3.28 | -16.75% |
| 2018 | $3.94 | 66.95% |
| 2017 | $2.36 | -56.30% |
| 2016 | $5.40 | 79.40% |
| 2015 | $3.01 | 9.45% |
| 2014 | $2.75 | -42.11% |
| 2013 | $4.75 | 5.56% |
| 2012 | $4.50 | 63.64% |
| 2011 | $2.75 | -47.62% |
| 2010 | $5.25 | -67.19% |
| 2009 | $16.00 | 48.84% |
| 2008 | $10.75 | -70.34% |
| 2007 | $36.25 | 49.48% |
| 2006 | $24.25 | 22.78% |
| 2005 | $19.75 | -7.06% |
| 2004 | $21.25 | 84.78% |
| 2003 | $11.50 | 142.11% |
| 2002 | $4.75 | -55.81% |
| 2001 | $10.75 | -37.45% |
| 2000 | $17.19 | -15.38% |
| 1999 | $20.31 | -36.59% |
| 1998 | $32.03 | -63.39% |
| 1997 | $87.50 | -29.11% |
| 1996 | $123.44 | 2.60% |
| 1995 | $120.31 | 52.48% |
| 1994 | $78.91 | -51.44% |
| 1993 | $162.50 | 6.12% |
| 1992 | $153.13 | 2.08% |
| 1991 | $150.00 | 115.73% |
| 1990 | $69.53 | -19.09% |
| 1989 | $85.94 | -4.35% |
| 1988 | $89.84 | 79.69% |
| 1987 | $50.00 | -13.04% |
| 1986 | $57.50 | -23.33% |
| 1985 | $75.00 | 74.76% |
| 1984 | $42.92 | -17.60% |
| 1983 | $52.08 | - |
Price of Anixa Biosciences compared to S&P500 (SPY/US500)
Anixa Biosciences currently underperform the market.
View the most expensive stocks in the world.
